Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Reddy

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Pre-treatment Microbiome Diversity and Function is associated with Expansion of Cytotoxic and Regulatory Immune Populations after N-803 treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Cancer Immunology Research|March 13, 2016
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCCAndrew Gabrielson, Yunan Wu, Hongkun Wang, et al.
Journal of the American Heart Association|April 29, 2023
Survey and Evaluation of Hypertension Machine Learning ResearchClea du Toit, Tran Quoc Bao Tran, Neha Deo, et al.
NEJM Evidence|February 6, 2024
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder CancerKarim Chamie, Sam S Chang, Eugene Kramolowsky, et al.
The Journal of Urology|September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder CancerSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary DiseaseSam S Chang, Karim Chamie, Charles A Seabury, et al.
The Journal of Urology|October 15, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|October 24, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2026
Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Pre-treatment Microbiome Diversity and Function is associated with Expansion of Cytotoxic and Regulatory Immune Populations after N-803 treatment in People with HIVAshma Chakrawarti, Ross T Cromarty, Christopher M Basting, et al.
Cancer Immunology Research|March 13, 2016
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCCAndrew Gabrielson, Yunan Wu, Hongkun Wang, et al.
Journal of the American Heart Association|April 29, 2023
Survey and Evaluation of Hypertension Machine Learning ResearchClea du Toit, Tran Quoc Bao Tran, Neha Deo, et al.
NEJM Evidence|February 6, 2024
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder CancerKarim Chamie, Sam S Chang, Eugene Kramolowsky, et al.
The Journal of Urology|September 16, 2025
Prolonged Progression-Free Survival, Disease-Free Survival, and Cystectomy Avoidance With IL-15 Receptor Lymphocyte-Stimulating Agent NAI Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin-Unresponsive Papillary-Only Nonmuscle-Invasive Bladder CancerSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|July 6, 2026
Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary DiseaseSam S Chang, Karim Chamie, Charles A Seabury, et al.
The Journal of Urology|October 15, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The Journal of Urology|October 24, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
Pageof 13